Our Bottom Line GLP1 microdosing might sound clever on TikTok or Reddit, but theres no credible evidence it works better and it may come with more risks than benefits
Larios didnt want to watch his new client lose, gain, lose again, then gain again, but thats how things started
Though not common, GLP-1 medications can trigger or worsen gastroparesis in some individuals
A 2023 study published in the Journal of Clinical Endocrinology and Metabolism found that GLP-1 receptor agonist therapy in women with obesity and insulin resistance produced significant improvements in androgen levels, menstrual regularity, and metabolic markers, with effects most pronounced in women with baseline hyperinsulinemia, underscoring how tightly GLP-1 mechanisms are connected to broader hormonal function in women
New England Journal of Medicine, 384 ,
The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript